Department of Biotechnology, Science Campus, Alagappa University, Karaikudi 630 003, India.
Department of Life Sciences, National University of Kaohsiung, Kaohsiung 811, Taiwan.
Biomolecules. 2020 Apr 2;10(4):536. doi: 10.3390/biom10040536.
Neurological diseases (NDs), especially Alzheimer's and Spinocerebellar ataxia (SCA), can severely cause biochemical abnormalities in the brain, spinal cord and other nerves of human beings. Their ever-increasing prevalence has led to a demand for new drug development. Indian traditional and Ayurvedic medicine used to combat the complex diseases from a holistic and integrative point of view has shown efficiency and effectiveness in the treatment of NDs. is a potent Indian medicinal herb used for multiple ailments, but is significantly known as a nootropic or brain tonic and memory enhancer. This annual herb has various active compounds and acts as an alternative and complementary medicine in various countries. However, system-level insights of the molecular mechanism of a multiscale treatment strategy for NDs is still a bottleneck. Considering its prominence, we used cheminformatics and system pharmacological approaches, with the aim to unravel the various molecular mechanisms represented by Bacopa-derived compounds in identifying the active human targets when treating NDs. First, using cheminformatics analysis combined with the drug target mining process, 52 active compounds and their corresponding 780 direct receptors were retrieved and computationally validated. Based on the molecular properties, bioactive scores and comparative analysis with commercially available drugs, novel and active compounds such as asiatic acid (ASTA) and loliolide (LLD) to treat the Alzheimer's and SCA were identified. According to the interactions among the active compounds, the targets and diseases were further analyzed to decipher the deeper pharmacological actions of the drug. NDs consist of complex regulatory modules that are integrated to dissect the therapeutic effects of compounds derived from Bacopa in various pathological features and their encoding biological processes. All these revealed that Bacopa compounds have several curative activities in regulating the various biological processes of NDs and also pave the way for the treatment of various diseases in modern medicine.
神经疾病(NDs),特别是阿尔茨海默病和脊髓小脑共济失调(SCA),会严重导致人类大脑、脊髓和其他神经的生化异常。它们的发病率不断上升,导致人们对新药开发的需求不断增加。印度传统和阿育吠陀医学从整体和综合的角度对抗复杂疾病,在治疗 NDs 方面显示出了疗效。葫芦巴是一种有效的印度药用植物,用于治疗多种疾病,但它作为益智药或大脑补品和记忆力增强剂而显著闻名。这种一年生草本植物含有多种活性化合物,在许多国家被用作替代和补充药物。然而,针对 NDs 的多尺度治疗策略的系统水平机制仍然是一个瓶颈。考虑到其重要性,我们使用化学信息学和系统药理学方法,旨在揭示葫芦巴衍生化合物在治疗 NDs 时所代表的各种分子机制的活性人类靶点。首先,我们使用化学信息学分析结合药物靶点挖掘过程,检索并计算验证了 52 种活性化合物及其对应的 780 个直接受体。基于分子特性、生物活性评分和与市售药物的比较分析,确定了新型和活性化合物,如葫芦巴酸(ASTA)和千里光内酯(LLD),用于治疗阿尔茨海默病和 SCA。根据活性化合物之间的相互作用,进一步分析靶点和疾病,以揭示药物更深层次的药理学作用。NDs 由复杂的调控模块组成,这些模块被整合以剖析葫芦巴衍生化合物在各种病理特征及其编码生物过程中的治疗效果。所有这些都表明,葫芦巴化合物在调节 NDs 的各种生物过程方面具有多种治疗活性,并为现代医学治疗各种疾病铺平了道路。